SurVaxM

DB17397InvestigationalVaccines

SurVaxM: Overview.

Mechanism: Pharmacologically active on Baculoviral IAP repeat-containing protein 5 and Hemocyanin 1
Curator reviewed
Also known as: SVN53-67/M57-KLH peptide vaccine
Code names: SVN53-67/M57-KLH

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

9Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with SurVaxM, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.